Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
These notes describe the products in the EDC guide.
Castor
Best for
Academic groups, biotechs and device teams running investigator-initiated or mid-size studies who want to build studies themselves.
What to consider
Castor has a large published study footprint and strong certifications, and teams can build studies without vendor help. It offers fewer native modules than the enterprise suites, and Everest Group placed it as a Major Contender rather than a Leader in 2024.
Sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users.
What to consider
Viedoc combines an Everest Group Leader rating with no-downtime study changes, strong certifications and a published pricing model. It has no native CTMS and no named eConsent module.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Castor vs Viedoc (EDC): category feature evidence and sources. Products are not ranked.
Category feature
Castor
Viedoc
Track record in regulated multi-site trialsFeature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Castor
Extended support
Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs.
The vendor reports study, participant and site adoption across a stated country count.
Study build and mid-study changesFeature definitions
Supported
Study setup or post-go-live study changes are described.
Extended support
Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Castor
Supported
Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.
eConsent, ePRO/eCOA and eSource establish connected modules; native supply and coding are not listed.
Viedoc
Extended support
Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.